Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia
Ocular Oncology and Pathology · 2021 · 7 (3) · 215-223
DOI: 10.1159/000511980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 21.01.2021. Verfasst von María Elena González und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Oncology Service, Hospital San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Intra-arterial chemotherapy (IAC) is useful for eye preservation in advanced retinoblastoma (Rb). Intra-vitreal chemotherapy (IvitC) is the latest treatment for vitreous seeds.
Methods
The present study is a retrospective assessment of 100 eyes, treated with primary or secondary IAC alone or with IvitC. We evaluated demographic and clinical variables, eye salvage, associated adverse events, and patient survival. Data were analyzed using descriptive statistics. Kaplan-Meier survival curves and Cox hazard ratios were utilized to assess the effect of demographic and clinical variables over eye salvage.
Results
Bilateral Rb was observed in 61% of patients, and 57% of eyes received secondary treatment. Forty eyes needed intra-arterial plus IvitC and 62 presented advanced disease (group D and E). Three- and 5-year ocular survival probabilities were 75 and 68%. We found a higher risk in group D and E eyes and those requiring 2 or more routes for ophthalmic artery catheterization. Patients coming from other countries also showed increased risk. Using primary or secondary treatment, or IvitC, did not affect this risk. Overall rates of survival and eye salvages were 98.8 and 73%, and we had a 100% catheterization success and none ophthalmic arterial occlusions.
Conclusions
In an upper middle-income country such as Colombia, a specialized institution counting with therapeutic alternatives and a multidisciplinary team can reach rates of patient survival and eye salvage similar to those of high-income countries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ocular Oncology Service, Hospital San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia.
- Paediatric Ophthalmology Service Hospital San Vicente Fundación, Universidad de Antioquia, Medellín, Colombia.
- Ophthalmology Service, Hospital San Vicente Fundación, Medellín, Colombia.
- Department of Interventional Neuroradiology, Hospital San Vicente Fundación, Medellín, Colombia.
- Medical School, Universidad CES, Medellín, Colombia.
Zitieren
APA
González, M. E., Gaviria, M. L., López, M., Escudero, P. A., Bravo, A., & Vargas, S. A. (2021). Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocular Oncology and Pathology, 7(3), 215-223. https://doi.org/10.1159/000511980
Vancouver
González ME, Gaviria ML, López M, Escudero PA, Bravo A, Vargas SA. Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia. Ocular Oncology and Pathology. 2021;7(3):215-223. doi:10.1159/000511980
BibTeX
@article{Gonzlez2021,
author = {González, María Elena and Gaviria, Martha Lia and López, Mariana and Escudero, Pablo Andrés and Bravo, Andrés and Vargas, Sergio Alberto},
title = {Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia},
journal = {Ocular Oncology and Pathology},
year = {2021},
volume = {7},
number = {3},
pages = {215--223},
doi = {10.1159/000511980}
}
EUVIMED